HIV Infections Clinical Trial
Official title:
HIV Symptom Management With African American Mothers
African American mothers infected with HIV face unique challenges in management of their disease. The goal of this study was to determine the effectiveness of an HIV self-care and symptom management program designed to help low-income African American mothers with HIV.
Infection with the human immunodeficiency virus (HIV) poses a growing threat to the health
of women in childbearing years and occurs disproportionately among lower socioeconomic
populations and minority women. Early identification of HIV infection and advances in
antiretroviral therapies have begun to prolong the lives of infected individuals. However,
women with HIV appear to have more rapid disease progression and shorter survival after
diagnosis than men. Evidence is emerging that women are less likely to use health services,
are more likely to present at clinical facilities with advanced disease, and are less likely
to receive antiretroviral therapy.
To date, little attention has focused on the prevention and management of symptoms
experienced by women with HIV before they develop AIDS. The primary aim of this randomized
clinical study was determine the efficacy of an HIV self-care and symptom management
intervention designed to help low-income African American mothers with HIV. The study was
based on the Maternal HIV Self-Care Symptom Management framework, which postulates that
helping mothers to cope with their emotional responses to HIV diagnosis and to reframe their
understanding of HIV from an immediate life-threatening illness to a chronic disease
decreases emotional distress and improves health.
One hundred and nine African American mothers, including 17 grandmothers who were primary
caregivers for children, participated in the trial. Women were randomized to either the
intervention or the control group. The intervention focused on the mother’s responses to her
HIV diagnosis and helped her understand, manage, and prevent selected HIV-related symptoms,
using her concern about her child(ren) as a motivator. The intervention used a cognitive
reframing educational approach based within a therapeutic relationship with an advanced
practice nurse. The nurse provided a culturally sensitive milieu designed to help the woman
feel safe in exploring her feelings and expressing her needs. Eight teaching modules
provided basic information to improve knowledge about HIV and help the mother identify
self-care strategies related to general health promotion. Data were collected using
self-report measures assessing emotional distress and health.
Mothers in the intervention group reported fewer feelings of stigma 6 months after the
intervention ended than did mothers in the control group. Within the intervention group,
there was a reduction in two aspects of affective state (depression/dejection and
tension/anxiety) and in stigma. However, most outcomes did not differ significantly. There
was no reduction in depressive symptoms, in other aspects of affective state, or in HIV
worry. Mothers in the intervention group reported higher physical function scores 6 months
after the intervention ended compared to control mothers. Other aspects of health-related
quality of life, such as perception of health, health distress, energy/fatigue, and role
function, did not improve. Within the intervention group, mothers reported fewer infections
from enrollment to 1 month after the intervention ended. In contrast, mothers in the control
group reported a decline in physical function and overall role function. There was a high
drop-out for mothers in both groups. Analysis of enrollment data comparing the mothers who
dropped out and mothers who remained in the study indicated that drop-out mothers had
significantly higher scores on emotional distress variables and social conflict and lower
perceptions of health, suggesting the need for a more targeted intervention with a stronger
focus on mental health.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05454514 -
Automated Medication Platform With Video Observation and Facial Recognition to Improve Adherence to Antiretroviral Therapy in Patients With HIV/AIDS
|
N/A | |
| Completed |
NCT03760458 -
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
|
Phase 1/Phase 2 | |
| Completed |
NCT03141918 -
Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS
|
N/A | |
| Completed |
NCT03067285 -
A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study
|
Phase 4 | |
| Recruiting |
NCT04579146 -
Coronary Artery Disease (CAD) in Patients HIV-infected
|
||
| Completed |
NCT06212531 -
Papuan Indigenous Model of Male Circumcision
|
N/A | |
| Active, not recruiting |
NCT03256422 -
Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients
|
Phase 3 | |
| Completed |
NCT03256435 -
Retention in PrEP Care for African American MSM in Mississippi
|
N/A | |
| Completed |
NCT00517803 -
Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
|
N/A | |
| Active, not recruiting |
NCT03572335 -
Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
|
||
| Completed |
NCT04165200 -
Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV
|
N/A | |
| Recruiting |
NCT03854630 -
Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection
|
Phase 4 | |
| Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
| Completed |
NCT02234882 -
Study on Pharmacokinetics
|
Phase 1 | |
| Completed |
NCT01618305 -
Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
|
Phase 4 | |
| Recruiting |
NCT05043129 -
Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
|
||
| Not yet recruiting |
NCT05536466 -
The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine
|
N/A | |
| Recruiting |
NCT04985760 -
Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy
|
Phase 1 | |
| Completed |
NCT05916989 -
Stimulant Use and Methylation in HIV
|
||
| Terminated |
NCT02116660 -
Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)
|
Phase 2 |